No Guts, No Loss: Toward the Ideal Treatment for Obesity in the Twenty-First Century

por Hope, David C. D., Tan, Tricia M. M., Bloom, Stephen R.
Publicado 2018

Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity

por Hope, David C. D., Vincent, Matthew L., Tan, Tricia M. M.
Publicado 2021

A glucagon analogue decreases body weight in mice via signalling in the liver

por Hinds, Charlotte E., Owen, Bryn M., Hope, David C. D., Pickford, Philip, Jones, Ben, Tan, Tricia M., Minnion, James S., Bloom, Stephen R.
Publicado 2021

Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss

por Hope, David C.D., Hinds, Charlotte E., Lopes, Tatiana, Vincent, Matthew L., Shrewsbury, Jed V., Yu, Arthur T.C., Davies, Iona, Scott, Rebecca, Jones, Ben, Murphy, Kevin G., Minnion, James S., Sardini, Alessandro, Carling, David, Lutz, Thomas A., Bloom, Stephen R., Tan, Tricia M.M., Owen, Bryn M.
Publicado 2022

Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals

por Izzi-Engbeaya, Chioma, Distaso, Walter, Amin, Anjali, Yang, Wei, Idowu, Oluwagbemiga, Kenkre, Julia S, Shah, Ronak J, Woin, Evelina, Shi, Christine, Alavi, Nael, Bedri, Hala, Brady, Niamh, Blackburn, Sophie, Leczycka, Martina, Patel, Sanya, Sokol, Elizaveta, Toke-Bjolgerud, Edward, Qayum, Ambreen, Abdel-Malek, Mariana, Hope, David C D, Oliver, Nick S, Bravis, Vasiliki, Misra, Shivani, Tan, Tricia M, Hill, Neil E, Salem, Victoria
Publicado 2021